KALM Therapeutics

Kalm Therapeutics is a company dedicated to revolutionizing the treatment of eczema and psoriasis. Founded by AJ Singhal, who was inspired by his daughter's struggle with eczema, the company has developed a groundbreaking treatment - the Kalm Patch. This innovative, plant-based patch provides continuous, 24-hour delivery of a natural, anti-inflammatory medication, offering relief from itching and scratching while promoting skin healing. Unlike traditional topical treatments, the Kalm Patch is designed to be safe and effective, providing a much-needed alternative to harmful steroids.

The company is led by a team of experienced professionals in the life sciences industry, including CEO Chris Seibert, CTO AJ Singhal, Chief Development Officer Dr. Tacey Viegas, and Chief Medical Officer Dr. Tomoko Maeda-Chubachi. Kalm Therapeutics is committed to providing hope and healing to patients suffering from inflammatory skin conditions, empowering them to live healthier and more fulfilling lives.

Kalm Therapeutics is a company dedicated to revolutionizing the treatment of inflammatory skin conditions like eczema and psoriasis. Driven by the personal experience of their founder, whose daughter struggled with eczema, Kalm seeks to provide patients with a safe, effective, and convenient alternative to traditional treatments. They have developed a natural, plant-based patch that delivers continuous medication over 24 hours, offering relief from itching, scratching, and the need for frequent applications of harmful steroids.

Kalm Therapeutics cultivates a culture of innovation and passion, driven by a personal mission to provide relief for those struggling with eczema and psoriasis. They prioritize the development of safe and effective treatments, emphasizing the importance of natural, plant-based ingredients and cutting-edge technology. The company fosters a collaborative and supportive environment, attracting experienced professionals who are dedicated to making a positive impact on the lives of patients.